Side-by-side comparison of mechanisms, dosing, interactions, and stacking potential.
| Lion's Mane (Hericium erinaceus) | Phenibut | |
|---|---|---|
| Category | Nootropics | Nootropics |
| Standard Dose | 500-3000 mg/day of fruiting body extract (standardized to >30% polysaccharides) or 1000-3000 mg/day of mycelium extract (erinacine-enriched) | 250-750 mg as needed, maximum 1-2 times per week (for educational context — carries significant dependence risk) |
| Timing | Morning or split morning/afternoon. With or without food. Effects are cumulative — expect 2-4 weeks before noticeable cognitive benefit. | On an empty stomach (food significantly reduces absorption). Onset 2-4 hours. Effects last 4-8 hours with residual effects up to 24 hours. Half-life approximately 5.3 hours. |
| Cycle Duration | Ongoing; no cycling strictly required, though some users cycle 8 weeks on, 2 weeks off | STRICTLY intermittent use only — maximum 1-2 times per week. NEVER use daily for more than 1 week. Tolerance develops within days, leading to dose escalation and dependence. |
| Evidence Level | moderate_human | moderate_human |
Contains hericenones (fruiting body) and erinacines (mycelium) that stimulate nerve growth factor (NGF) synthesis in glial cells via activation of the JNK pathway. Erinacines cross the blood-brain barrier via passive diffusion and act as potent neurotrophin-stimulating compounds, activating the TrkA receptor and downstream ERK1/2 signaling cascades to promote hippocampal neurogenesis and synaptic plasticity. Also demonstrates anti-inflammatory activity through suppression of NF-kB and upregulation of BDNF expression.
500-3000 mg/day of fruiting body extract (standardized to >30% polysaccharides) or 1000-3000 mg/day of mycelium extract (erinacine-enriched)
Morning or split morning/afternoon. With or without food. Effects are cumulative — expect 2-4 weeks before noticeable cognitive benefit.
Ongoing; no cycling strictly required, though some users cycle 8 weeks on, 2 weeks off
Beta-phenyl derivative of GABA that crosses the blood-brain barrier (unlike GABA itself) due to the addition of a phenyl ring. Acts as a full agonist at GABA-B receptors with 30-68x lower affinity than baclofen, requiring correspondingly higher doses. Also binds to and blocks alpha-2-delta subunit-containing voltage-dependent calcium channels (VDCCs), making it a gabapentinoid similar to gabapentin and pregabalin. At low concentrations, mildly increases dopamine levels in the brain, providing stimulatory and nootropic effects alongside anxiolysis. Weak agonist activity at GABA-A receptors at higher doses.
250-750 mg as needed, maximum 1-2 times per week (for educational context — carries significant dependence risk)
On an empty stomach (food significantly reduces absorption). Onset 2-4 hours. Effects last 4-8 hours with residual effects up to 24 hours. Half-life approximately 5.3 hours.
STRICTLY intermittent use only — maximum 1-2 times per week. NEVER use daily for more than 1 week. Tolerance develops within days, leading to dose escalation and dependence.
Take our free assessment to get personalized recommendations based on your health goals, current stack, and biomarkers.
Get Your Free Protocol →or take the assessment →